Precision 're'arming of CD33 antibodies

被引:1
|
作者
Borthakur, Gautam [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
CELLS;
D O I
10.1182/blood-2013-06-509638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1334 / 1334
页数:1
相关论文
共 50 条
  • [21] The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia
    Olombel, Guillaume
    Guerin, Estelle
    Guy, Julien
    Perrot, Jean-Yves
    Dumezy, Florent
    de labarthe, Adrienne
    Bastie, Jean-Noel
    Legrand, Ollivier
    Raffoux, Emmanuel
    Plesa, Adriana
    Wagner-Ballon, Orianne
    Cornet, Edouard
    Salaun, Veronique
    Preudhomme, Claude
    Thomas, Xavier
    Pautas, Cecile
    Chantepie, Sylvain
    Turlure, Pascal
    Castaigne, Sylvie
    Dombret, Herve
    Feuillard, Jean
    BLOOD, 2016, 127 (17) : 2157 - +
  • [22] Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
    Pollard, Jessica A.
    Alonzo, Todd A.
    Loken, Michael
    Gerbing, Robert B.
    Ho, Phoenix A.
    Bernstein, Irwin D.
    Raimondi, Susana C.
    Hirsch, Betsy
    Franklin, Janet
    Walter, Roland B.
    Gamis, Alan
    Meshinchi, Soheil
    BLOOD, 2012, 119 (16) : 3705 - 3711
  • [23] FLUID-MECHANICAL FORCES IN AGITATED BIOREACTORS REDUCE THE CD13 AND CD33 SURFACE PROTEIN-CONTENT OF HL-60 CELLS
    LAKHOTIA, S
    BAUER, KD
    PAPOUTSAKIS, ET
    BIOTECHNOLOGY AND BIOENGINEERING, 1993, 41 (09) : 868 - 877
  • [24] Inhibitor of bromodomain and extraterminal domain proteins decreases transcription of Cd33 in the brain of mice subjected to systemic inflammation; a promising strategy for neuroprotection
    Czapski, Grzegorz A.
    Matuszewska, Marta
    Cieslik, Magdalena
    Mossakowski, Joanna B. Strosznajder
    FOLIA NEUROPATHOLOGICA, 2024, 62 (02) : 127 - 135
  • [25] CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway
    Hernandez-Caselles, Trinidad
    Corral-San Miguel, Ruben
    Jose Ruiz-Alcaraz, Antonio
    Garcia-Penarrubia, Pilar
    JOURNAL OF IMMUNOLOGY RESEARCH, 2019, 2019
  • [26] Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+cells
    Ogata, Kiyoyuki
    Sei, Kazuma
    Saft, Leonie
    Kawahara, Naoya
    Della Porta, Matteo G.
    Chapuis, Nicolas
    Yamamoto, Yumi
    LEUKEMIA RESEARCH, 2018, 71 : 75 - 81
  • [27] Associations between CD33 rs3865444 and ABCA7 rs3764650 polymorphisms and susceptibility to Alzheimer's disease
    Wang, Jing
    Kong, Xiangyi
    Cong, Lele
    Xu, Zhongxin
    Du, Jianshi
    Cong, Xianling
    Sun, Hongyan
    Xu, Yanan
    Zhao, Qing
    JOURNAL OF INTEGRATIVE NEUROSCIENCE, 2018, 17 (04) : 313 - 321
  • [28] CD33 monoclonal antibody conjugated Au cluster nano-bioprobe for targeted flow-cytometric detection of acute myeloid leukaemia
    Retnakumari, Archana
    Jayasimhan, Jasusri
    Chandran, Parwathy
    Menon, Deepthy
    Nair, Shantikumar
    Mony, Ullas
    Koyakutty, Manzoor
    NANOTECHNOLOGY, 2011, 22 (28)
  • [29] Quantitative analyses of CD7, CD33, CD34, CD56, and CD123 within the FLT3-ITD/NPM1-MUT myeloblastic/monocytic bulk AML blastic populations
    Soare, Dan-Sebastian
    Radu, Eugen
    Dumitru, Ion
    Vladareanu, Ana Maria
    Bumbea, Horia
    LEUKEMIA & LYMPHOMA, 2021, 62 (11) : 2716 - 2726
  • [30] Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin-Containing Chemotherapy
    Mortland, Leslie
    Alonzo, Todd A.
    Walter, Roland B.
    Gerbing, Robert B.
    Mitra, Amit K.
    Pollard, Jessica A.
    Loken, Michael R.
    Hirsch, Betsy
    Raimondi, Susana
    Franklin, Janet
    Pounds, Stanley
    Cao, Xueyuan
    Rubnitz, Jeffrey E.
    Ribeiro, Raul C.
    Gamis, Alan
    Meshinchi, Soheil
    Lamba, Jatinder K.
    CLINICAL CANCER RESEARCH, 2013, 19 (06) : 1620 - 1627